| Product Code: ETC6746857 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Major Depressive Disorder Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Major Depressive Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 China Major Depressive Disorder Market - Industry Life Cycle |
3.4 China Major Depressive Disorder Market - Porter's Five Forces |
3.5 China Major Depressive Disorder Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 China Major Depressive Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about mental health and the importance of seeking treatment for major depressive disorder in China |
4.2.2 Growing acceptance and adoption of evidence-based therapies for treating major depressive disorder |
4.2.3 Rising prevalence of major depressive disorder cases in China due to various socio-economic factors |
4.3 Market Restraints |
4.3.1 Stigma associated with mental health disorders leading to underreporting and undertreatment of major depressive disorder in China |
4.3.2 Limited access to mental health professionals and specialized treatment facilities in certain regions of China |
4.3.3 High cost of treatment for major depressive disorder, including therapy sessions and medication, impacting affordability for some patients |
5 China Major Depressive Disorder Market Trends |
6 China Major Depressive Disorder Market, By Types |
6.1 China Major Depressive Disorder Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 China Major Depressive Disorder Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 China Major Depressive Disorder Market Revenues & Volume, By Auvelity (Bupropion/dextromethorphan), 2021- 2031F |
6.1.4 China Major Depressive Disorder Market Revenues & Volume, By Lexapro (Escitalopram), 2021- 2031F |
6.1.5 China Major Depressive Disorder Market Revenues & Volume, By Paxil (Paroxetine), 2021- 2031F |
6.1.6 China Major Depressive Disorder Market Revenues & Volume, By Zoloft (Sertraline), 2021- 2031F |
6.1.7 China Major Depressive Disorder Market Revenues & Volume, By Viibryd (Vilazodone), 2021- 2031F |
6.1.8 China Major Depressive Disorder Market Revenues & Volume, By SEP-363856, 2021- 2031F |
6.1.9 China Major Depressive Disorder Market Revenues & Volume, By REL-1017, 2021- 2031F |
6.1.10 China Major Depressive Disorder Market Revenues & Volume, By REL-1017, 2021- 2031F |
7 China Major Depressive Disorder Market Import-Export Trade Statistics |
7.1 China Major Depressive Disorder Market Export to Major Countries |
7.2 China Major Depressive Disorder Market Imports from Major Countries |
8 China Major Depressive Disorder Market Key Performance Indicators |
8.1 Number of individuals seeking mental health services specifically for major depressive disorder in China |
8.2 Percentage increase in the utilization of evidence-based therapies for major depressive disorder treatment |
8.3 Average wait time for individuals seeking treatment for major depressive disorder in China |
9 China Major Depressive Disorder Market - Opportunity Assessment |
9.1 China Major Depressive Disorder Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 China Major Depressive Disorder Market - Competitive Landscape |
10.1 China Major Depressive Disorder Market Revenue Share, By Companies, 2024 |
10.2 China Major Depressive Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here